US$ 24.59
is toujeo a glp 1 Diabetes Patients Also Struggle to Access GLP-1 Agonists Toujeo (insulin glargine): Uses, Side
Description
Here is the time-to-event analysis which again shows the non-fatal heart attack (MI) reduction, whereas nonfatal stroke was not significantly reduced (a 7% relative reduction)
Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, et al

Clinical Evidence Gap: OTC Claims vs

Recommendation tiers: (i) Strongly Recommended: GLP-1RAs may be used as time-bounded metabolic optimization before OI or ART, aiming to improve metabolic readiness prior to stimulation and pregnancy planning

For most patients, the established benefits of GLP-1 therapy in managing diabetes and obesity far outweigh theoretical concerns about pancreatic cancer that have not been supported by current evidence
